BMY
BRISTOL MYERS SQUIBB CO
NYSE · Healthcare · Drug Manufacturers - General · US
$63.14
+2.32%Margins
Gross margin
69.2%
EBITDA margin
30.3%
EBIT margin
26.1%
Net margin
18.5%
FCF margin
18.6%
39.5%
Return on equity
10.4%
Return on assets
19.1%
Return on invested capital
0.57x
Asset turnover
$10.7B
Cash from operations
$6.15
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026